Tal Zvi Zaks Moderna, Inc. (MRNA) insider trading activity

Tal Zvi Zaks is Chief Medical Officer of Moderna, Inc.. Currently has a direct ownership of 0 shares of MRNA, which is worth approximately $0. The most recent transaction as insider was on Apr 12, 2021, when has been sold 5,000 shares (Common Stock) at a price of $12.21 per share, resulting in proceeds of $61,050. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Tal Zvi Zaks Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 12 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Apr 05 2021	SELL Open market or private sale	$646,650 $129.33 p/Share	5,000 Reduced 100.0%	0 Common Stock
Apr 05 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Mar 22 2021	SELL Open market or private sale	$174,167 $145.26 p/Share	1,199 Reduced 100.0%	0 Common Stock
Mar 22 2021	BUY Exercise of conversion of derivative security	$25,095 $20.93 p/Share	1,199 Added 50.0%	1,199 Common Stock
Mar 15 2021	SELL Open market or private sale	$1,401,348 $139.66 p/Share	10,034 Reduced 100.0%	0 Common Stock
Mar 15 2021	BUY Exercise of conversion of derivative security	$176,398 $17.58 p/Share	10,034 Added 50.0%	10,034 Common Stock
Mar 08 2021	SELL Open market or private sale	$2,112,315 $128.19 p/Share	16,478 Reduced 100.0%	0 Common Stock
Mar 08 2021	BUY Exercise of conversion of derivative security	$260,188 $15.79 p/Share	16,478 Added 50.0%	16,478 Common Stock
Mar 01 2021	SELL Open market or private sale	$1,519,900 $151.99 p/Share	10,000 Reduced 100.0%	0 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	$132,200 $13.22 p/Share	10,000 Added 50.0%	10,000 Common Stock
Feb 22 2021	SELL Open market or private sale	$824,900 $164.98 p/Share	5,000 Reduced 100.0%	0 Common Stock
Feb 22 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Feb 08 2021	SELL Open market or private sale	$670,546 $182.71 p/Share	3,670 Reduced 100.0%	0 Common Stock
Feb 08 2021	BUY Exercise of conversion of derivative security	$44,811 $12.21 p/Share	3,670 Added 50.0%	3,670 Common Stock
Feb 01 2021	SELL Open market or private sale	$818,350 $163.67 p/Share	5,000 Reduced 100.0%	0 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Jan 25 2021	SELL Open market or private sale	$712,550 $142.51 p/Share	5,000 Reduced 100.0%	0 Common Stock
Jan 25 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Jan 19 2021	SELL Open market or private sale	$618,150 $123.63 p/Share	5,000 Reduced 100.0%	0 Common Stock
Jan 19 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Jan 11 2021	SELL Open market or private sale	$582,800 $116.56 p/Share	5,000 Reduced 100.0%	0 Common Stock
Jan 11 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Jan 04 2021	SELL Open market or private sale	$543,500 $108.7 p/Share	5,000 Reduced 100.0%	0 Common Stock
Jan 04 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock

Also insider at

ADAP

Adaptimmune Therapeutics PLC Healthcare

Director

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD Healthcare

TZZ

Tal Zvi Zaks

Chief Medical Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account